Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Director departure
Appointed director
CC transcript
|
|
FOXO TECHNOLOGIES INC.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2023 |
8-K
| Conference call transcript|
Docs:
|
"FOXO Technologies™ Announces Full Year 2022 Financial Results and Recent Business Highlights MINNEAPOLIS, MN, MARCH 30, 2023 — FOXO Technologies Inc. , a leader in commercializing epigenetic biomarkers of health and aging in life insurance, today reported financial results for the full year ended December 31, 2022 and accompanying business highlights. “I am truly excited with the future we are building,” said Tyler Danielson, interim CEO and Chief Technology Officer of FOXO. “The challenges faced in 2022 presented us with an opportunity to take a comprehensive assessment of our business and the way we approach the market. We sought to reset our vision and mission, and identify the clear objectives that we believe are necessary to achieve them and hold ourselves accountable. Our aim i...",
"Transcript of Conference Call held on March 30, 2023" |
|
|
|